Allspring Global Investments
TNGX icon

Allspring Global Investments’s Tango Therapeutics TNGX Stock Holding History

Allspring Global Investments’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,157
Closed -$91.8K – 2724
2023
Q3 		$91.8K Sell
8,157
-6,315
-44% -$38.5K ﹤0.01% 2031
2023
Q2 		$48K Buy
+14,472
New +$52.1K ﹤0.01% 2298
2023
Q1 		– Sell
-28,730
Closed -$208K – 2937
2022
Q4 		$208K Sell
28,730
-42,253
-60% -$297K ﹤0.01% 1815
2022
Q3 		$256K Buy
+70,983
New +$303K ﹤0.01% 1749

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Allspring Global Investments's TNGX Position: Q4 2023 in Review

Allspring Global Investments sold out of Tango Therapeutics (TNGX) in Q4 2023, closing a stake of 8,157 shares — an estimated $91.8K sold.

Allspring Global Investments first reported a position in TNGX in Q3 2022 and held it in 4 quarters. The position peaked at $256K in Q3 2022. 121 funds tracked by Wall St. Rank hold TNGX as of Q4 2023.

  • Allspring Global Investments reported no remaining Tango Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 8,157 Tango Therapeutics shares in Q4 2023, an estimated $91.8K.
  • Allspring Global Investments first reported a position in Tango Therapeutics in Q3 2022 and held it in 4 quarters.
  • Allspring Global Investments's Tango Therapeutics position peaked at $256K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.